In addition, data mining further confirmed lower GCNT2 mRNA levels in clinical metastatic melanoma specimens compared to primary melanoma specimens from two of three independent clinical cohorts29–31 (Fig. 3g). This evidence concerns the gene GCNT2 and metastatic melanoma.